April 23, 2019 7:59am

A blank slate impedes the sector; otherwise we are relegated to the outcomes of traders, pools and algorithms

What goes down always comes back, it just timing – plant your fingers near a BUY button and risk a move

News: Athersys (ATHX) partner, HEALIOS K.K. has enrolled the first patient in its ONE-BRIDGE study in Japan, evaluating MultiStem® cell therapy treatment of patients who suffer from acute respiratory distress syndrome (ARDS)

Pre-open indications:  4 BUYs, 1 SELL and 3 TRADEs

If you think you understand perception, review your “positions” and think again then again. There is a “heck” of a lot of negative sentiment; liquidity remains a cause for concern!

Members only. Please login.